Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We had characterized earlier the novel tumor suppressor gene
hepatocellular carcinoma suppressor 1
(
HCCS1
), and demonstrated that expression of exogenous
HCCS1
gene in human
hepatocarcinoma
cells could remarkably suppress their abilities to develop tumors in nude mice and to form colonies in soft agar. In this study, we provide further experimental evidence to confirm the role of
HCCS1
as a tumor suppressor gene and investigate its potential in therapeutic applications by using adenovirus vectors. We show that
HCCS1
overexpression, mediated by replication-deficient adenovirus, significantly suppressed the growth of human colorectal cancer cells, as well as
hepatocellular carcinoma
cells in vitro and in vivo. To further improve its antitumor efficacy, we inserted the
HCCS1
gene into an oncolytic adenovirus. This
HCCS1
-armed oncolytic adenovirus exhibited a dramatic inhibitory effect on cancer cells in vitro and in vivo, and led to a complete regression of 50% of established tumor xenografts in nude mice. Taken together, our data suggest that
HCCS1
is a promising therapeutic gene for the treatment of human cancers.
...
PMID:Adenovirus-mediated HCCS1 overexpression elicits a potent antitumor efficacy on human colorectal cancer and hepatoma cells both in vitro and in vivo. 1861 15
We previously demonstrated that
hepatocellular carcinoma suppressor 1
(
HCCS1
) exerts potent anti-tumor activity. In this study, we constructed a new dual tumor-targeting oncolytic adenovirus vector, PD55-
HCCS1
, in which E1A was driven by the promoter of progression elevated gene-3, which is
hepatoma
-specific, and a CMV-
HCCS1
expression cassette replaced E1B55. The PD55-
HCCS1
-mediated selective expression of E1A and
HCCS1
in
hepatoma
cells and tumor-selective cytotoxicity in vitro and in vivo demonstrated the strongest inhibition of BEL-7404 cell xenografts in nude mice among a number of control Ad vectors. These data indicated the efficacy and safety of the PD55-
HCCS1
system for
HCC
treatment.
...
PMID:Potent anti-hepatoma efficacy of HCCS1 via dual tumor-targeting gene-virotherapy strategy. 1894 98